Here's the live share price of Alkem Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Alkem Laboratories | -0.52 | 1.56 | -6.09 | -2.32 | -4.78 | 13.19 | 5.85 |
| Sun Pharmaceutical Industries | -1.77 | -3.59 | -8.05 | 7.09 | 6.03 | 15.59 | 15.99 |
| Divi's Laboratories | -2.83 | 0.92 | 33.78 | 52.75 | 41.51 | 35.44 | 12.07 |
| Torrent Pharmaceuticals | -2.99 | -4.43 | -6.33 | 10.91 | 31.68 | 34.79 | 24.26 |
| Zydus Lifesciences | -2.50 | 2.91 | 0 | 22.52 | 13.83 | 24.11 | 15.69 |
| Laurus Labs | -0.14 | 6.66 | 31.68 | 88.53 | 134.18 | 71.86 | 26.44 |
| Cipla | -0.97 | -2.28 | -6.78 | 9.80 | -14.96 | 4.43 | 7.80 |
| Dr. Reddy's Laboratories | 2.52 | 7.82 | 0.41 | 0.36 | -1.77 | 4.31 | 4.68 |
| Mankind Pharma | -4.68 | 3.51 | -5.59 | 13.93 | -2.98 | 9.80 | 10.72 |
| Aurobindo Pharma | -0.41 | 1.09 | 8.61 | 25.63 | 48.05 | 22.30 | 18.23 |
| Lupin | -3.69 | -4.64 | -21.53 | -15.24 | -0.52 | 18.13 | 15.26 |
| Glenmark Pharmaceuticals | -0.96 | -4.54 | -1.49 | 3.32 | 18.62 | 41.71 | 33.74 |
| Biocon | -4.76 | -7.86 | -14.49 | 1.77 | 0.50 | 11.32 | -0.07 |
| Abbott India | -1.64 | -1.70 | -6.15 | -0.10 | -14.22 | 4.68 | 3.57 |
| Gland Pharma | 2.38 | 6.88 | 25.13 | 78.81 | 59.60 | 23.83 | -4.01 |
| Anthem Biosciences | -2.16 | -7.65 | 16.47 | 19.27 | 10.90 | 6.02 | 3.57 |
| Ipca Laboratories | -1.32 | -0.72 | 5.28 | 32.37 | 45.17 | 26.06 | 10.22 |
| GlaxoSmithKline Pharmaceuticals | -8.23 | -10.06 | 4.70 | 5.03 | -8.00 | 18.35 | 11.37 |
| Ajanta Pharma | -6.58 | -4.70 | -2.40 | 15.38 | 38.20 | 23.42 | 17.29 |
| Emcure Pharmaceuticals | -2.78 | -6.28 | 4.27 | 14.65 | 36.49 | 11.21 | 6.58 |
Source: Dion Global
Over the last one year, Alkem Laboratories has declined 4.78% compared to peers like Sun Pharmaceutical Industries (6.03%), Divi's Laboratories (41.51%), Torrent Pharmaceuticals (31.68%). From a 5 year perspective, Alkem Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (15.99%) and Divi's Laboratories (12.07%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 5,254.94 | 5,262.51 |
| 10 | 5,242.61 | 5,259.21 |
| 20 | 5,252.64 | 5,267.38 |
| 50 | 5,361.15 | 5,328.72 |
| 100 | 5,417.79 | 5,387.63 |
| 200 | 5,476.37 | 5,415.64 |
Source: Dion Global
In the latest quarter, Alkem Laboratories saw a drop in promoter holding to 49.70%, while DII stake increased to 22.64%, FII holding rose to 10.42%, and public shareholding unchanged at 17.25% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 32,76,928 | 1.61 | 1,746.44 | |
| 15,49,513 | 0.94 | 825.81 | |
| 14,76,712 | 1.86 | 787.01 | |
| 12,30,397 | 1.25 | 655.74 | |
| 8,92,035 | 1.34 | 475.41 | |
| 6,60,928 | 1.96 | 352.24 | |
| 6,51,772 | 1.89 | 347.36 | |
| 6,45,036 | 1.64 | 343.77 | |
| 6,39,791 | 4.87 | 340.98 | |
| 4,58,965 | 0.23 | 244.61 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 12, 2026, 09:13 PM IST IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
| Sep 24, 2026, 06:13 AM IST IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Cessation |
| Sep 23, 2026, 07:56 PM IST IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 21, 2026, 11:14 PM IST IST | Alkem Laboratories - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations |
| Sep 16, 2026, 05:19 PM IST IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Source: Dion Global
Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 9663.91 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Alkem Laboratories is ₹5,235.50 as on Oct 13, 2026.
The Alkem Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Alkem Laboratories is ₹62,598.26 Cr as on Oct 13, 2026.
Today’s highest and lowest price of Alkem Laboratories are ₹5,270.00 and ₹5,187.95.
The 52-week high/low is the highest and lowest price at which Alkem Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Alkem Laboratories is ₹5,933.00 and 52-week low of Alkem Laboratories is ₹5,052.05 as on Oct 13, 2026.
The Alkem Laboratories has shown returns of 0.2% over the past day, 1.56% for the past month, -6.09% over 3 months, -4.78% over 1 year, 13.19% across 3 years, and 5.85% over 5 years.
P/E ratio of and PB ratio of Alkem Laboratories are 29.01 and 4.36 on Oct 13, 2026. While the company gives a dividend yield of 1.01 per annum.
Source: Dion Global